antibacterial compounds (Cumbre/The Global Alliance for TB Drug Development)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Nameantibacterial compounds (Cumbre/The Global Alliance for TB Drug Development)
Drug Alias Nameantibacterial compounds (Cumbre/TB Alliance)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsTuberculosisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCumbre Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCumbre PharmaceuticalsTb Alliance
Active IndicationsN/A
Inactive IndicationsTuberculosisBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A